Evolving therapeutic paradigms for advanced prostate cancer: what's needed to make optimal use of the new treatments
Petrylak, D.P.
Oncology 25(6): 514-515
2011
ISSN/ISBN: 0890-9091 PMID: 21717906 Document Number: 654338
Document emailed within 1 workday
Related Documents
Kao, S.; Kiss, A.; Efimova, T.; Friedman, A.J. 2018: Managing Seborrheic Keratosis: Evolving Strategies and Optimal Therapeutic Outcomes Journal of Drugs in Dermatology: Jdd 17(9): 933-940Jackson, K.M.; Frazier, M.C.; Harris, W.B. 2007: Suppression of androgen receptor expression by dibenzoylmethane as a therapeutic objective in advanced prostate cancer Anticancer Research 27(3b): 1483-1488
Kelly, W.K.; Slovin, S.; Scher, H.I. 1996: Clinical use of posttherapy prostate-specific antigen changes in advanced prostate cancer Seminars in Oncology 23(6 Suppl 14: 8-14
Fischinger, P.J. 1994: The evolving perspective of prostate cancer: a question of natural history and current treatment trends Journal of the South Carolina Medical Association 90(5): 242-248
Stromberg, J.S.; Martinez, A.A.; Horwitz, E.M.; Gustafson, G.S.; Gonzalez, J.A.; Spencer, W.F.; Brabbins, D.S.; Dmuchowski, C.F.; Hollander, J.B.; Vicini, F.A. 1997: Conformal high dose rate iridium-192 boost brachytherapy in locally advanced prostate cancer: superior prostate-specific antigen response compared with external beam treatment Cancer Journal from Scientific American 3(6): 346-352
Loeb, S.; Schaeffer, E.M. 2009: Optimal therapy in localized prostate cancer: an unfolding story Oncology 23(10): 843; 846
Small, E.J.; Dawson, N.A.; Kantoff, P.W.; Vogelzang, N.J. 1996: Cancer and Leukemia Group B trials for advanced prostate cancer Seminars in Oncology 23(6 Suppl 14: 28-31
Fournier, G. 1994: Management of advanced prostate cancer La Revue du Praticien 44(5): 595-600
Orovan, W.L. 1989: Treatment of advanced cancer of the prostate Canadian Journal of Surgery. Journal Canadien de Chirurgie 32(5): 315-316
Pannuti, F.; Martoni, A.; Farabegoli, G.; Piana, E. 1985: Prolactin levels and hormonal profile in postmenopausal patients with advanced breast cancer during endocrine treatments Chemioterapia: International Journal of the Mediterranean Society of ChemoTherapy 4(2): 127-134
Faris, G.; Stein, A.; Lurie, A. 1993: Hormonal treatment of advanced prostate cancer Harefuah 124(1): 35-40
Olapade-Olaopa, E.O.; Obamuyide, H.A.; Yisa, G.T. 2008: Management of advanced prostate cancer in Africa Canadian Journal of Urology 15(1): 3890-3898
Fosså, S.D. 1996: Quality of life in advanced prostate cancer Seminars in Oncology 23(6 Suppl 14: 32-34
Baltogiannis, D.; Giannakopoulos, X.; Charalabopoulos, K.; Sofikitis, N. 2004: Monotherapy in advanced prostate cancer: an overview Experimental Oncology 26(3): 185-191
González-Del-Alba Baamonde, A.án.; Sevillano Fernández, E. 2018: The role of corticoids in the management of advanced prostate cancer Archivos Espanoles de Urologia 71(3): 281-287
Kurokawa, K.; Suzuki, K.; Yamanaka, H. 2003: Treatment strategy for locally advanced prostate cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(1): 38-42
Giannakopoulos, X.; Stagikas, D.; Peschos, D.; Batistatou, A.; Charalabopoulos, K. 2007: Implication of protocadherin-PC in the progression of the advanced prostate cancer Experimental Oncology 29(1): 74-75
Pa-C, K.B.O.; Pienta, K.J. 1999: Pain management in patients with advanced prostate cancer Oncology 13(11): 1537-1549; Discussion: 1549-1550 Passim
Azuma, H.; Katsuoka, Y. 2006: Treatment for locally advanced prostate cancer: value of surgery Hinyokika Kiyo. Acta Urologica Japonica 52(6): 459-467
Swanson, G.P. 2007: Treatment options in locally advanced prostate cancer Minerva Urologica e Nefrologica 59(1): 27-42